Sign In
Samples
/
Arexvy
Vaccines
Arexvy
respiratory syncytial virus vaccine
Manufacturer
GlaxoSmithKline
Indication
RSV prevention (adults 60+)
Sample Info:
77% effective in preventing RSV-associated ED encounters.
Check My Eligibility
How It Works
1
Enter your NPI number and email address
2
We check your eligibility with GlaxoSmithKline
3
Order samples instantly or request access
Free for healthcare providers
350K+ providers use PrescriberPoint
More from GlaxoSmithKline
View all
Shingrix
zoster vaccine recombinant, adjuvanted
Vaccines
Trelegy Ellipta
fluticasone furoate/umeclidinium/vilanterol
Respiratory
Dovato
dolutegravir/lamivudine
HIV
Nucala
mepolizumab
Respiratory
Breo Ellipta
fluticasone furoate/vilanterol
Respiratory
Benlysta
belimumab
Immunology
More Vaccines Samples
View all
Gardasil 9
human papillomavirus 9-valent vaccine
Merck
Prevnar 20
pneumococcal 20-valent conjugate vaccine
Pfizer
Popular Samples
Browse all
Ozempic
semaglutide injection
Novo Nordisk
Diabetes
Eliquis
apixaban
Pfizer
Cardiovascular
Keytruda
pembrolizumab
Merck
Oncology
Dupixent
dupilumab
Sanofi
Immunology
Eylea
aflibercept
Regeneron
Ophthalmology
Xarelto
rivaroxaban
Janssen (J&J)
Cardiovascular
105+
Products Available
50+
Manufacturers
20+
Therapeutic Areas
Arexvy (respiratory syncytial virus vaccine) Drug Samples | PrescriberPoint | PrescriberPoint